GlassScriptPhysician profile
Gaetano J Capone
NPI 1669437604
$2,278.33
in general payments reported to CMS, 2019-2025
24 companies · $344 in 2025
The $344 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $603 · 2020: $77.00 · 2021: $181 · 2022: $361 · 2023: $331 · 2024: $381 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,056.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,055.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $389.19 | 2019-2025 | Watchman Flx, Watchman Access System |
| Daiichi Sankyo INC. | $243.63 | 2023-2025 | Injectafer |
| Pfizer INC. | $222.51 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $201.32 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $173.38 | 2019-2025 | Wainua, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $146.76 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $123.91 | 2022-2023 | Verquvo |
| Amgen INC. | $123.38 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $97.10 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $87.87 | 2019-2021 | |
| Edwards Lifesciences Corporation | $59.03 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Lexicon Pharmaceuticals, INC. | $58.23 | 2023-2024 | Inpefa |
| Philips North America LLC | $53.20 | 2022-2024 | (Ck4) Mcot |
| Scpharmaceuticals INC. | $37.93 | 2024 | |
| Abbott Laboratories | $34.23 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Jot Dx |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $32.75 | 2022 | |
| Alnylam Pharmaceuticals INC. | $32.71 | 2025 | Onpattro |
| Kiniksa Pharmaceuticals International, Plc | $31.74 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $30.60 | 2024 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $27.49 | 2023 | Camzyos |
| Inspire Medical Systems, INC. | $21.83 | 2025 | Inspire |
| Preventice Services, LLC | $17.76 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $17.38 | 2023 | Arcalyst |
| Watermark Medical, INC. | $14.40 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gaetano Capone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.